PCA
SANA icon

Pallas Capital Advisors’s Sana Biotechnology SANA Stock Holding History

Pallas Capital Advisors’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105K Sell
30,221
-9,024
-23% -$29.1K ﹤0.01% 948
2026
Q1 		$113K Sell
39,245
-382
-1% -$1.5K ﹤0.01% 796
2025
Q4 		$161K Hold
39,627
– – 0.01% 828
2025
Q3 		$141K Buy
39,627
+63
+0.2% +$228 0.01% 812
2025
Q2 		$108K Buy
39,564
+22,005
+125% +$45.4K ﹤0.01% 794
2025
Q1 		$29.5K Buy
+17,559
New +$49.1K ﹤0.01% 738

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Pallas Capital Advisors's SANA Position: Q2 2026 in Review

Pallas Capital Advisors reduced its Sana Biotechnology (SANA) stake by 23% in Q2 2026, selling an estimated $29.1K and leaving 30,221 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #948.

Pallas Capital Advisors first reported a position in SANA in Q1 2025 and has held it in 6 quarters since. The position peaked at $161K in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Pallas Capital Advisors held 30,221 shares of Sana Biotechnology worth $105K as of Q2 2026.
  • Pallas Capital Advisors sold 9,024 Sana Biotechnology shares in Q2 2026, an estimated $29.1K.
  • Sana Biotechnology made up ﹤0.01% of Pallas Capital Advisors's portfolio in Q2 2026, its #948 holding.
  • Pallas Capital Advisors first reported a position in Sana Biotechnology in Q1 2025 and has held it in 6 quarters since.
  • Pallas Capital Advisors's Sana Biotechnology position peaked at $161K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.